Leadership Overview
Proxima Research International has 6 executives leading key functions including strategy, revenue generation, information technology, human resources, financial management, and operational scaling.
Focused on advancing pharmaceutical intelligence, Proxima Research International delivers data-driven insights to optimize market access and commercial performance across global healthcare ecosystems.
Focused on advancing pharmaceutical intelligence, Proxima Research International delivers data-driven insights to optimize market access and commercial performance across global healthcare ecosystems.
Leadership Roles at Proxima Research International
Oleksandr Khraban - Chief Executive Officer
Oleksandr Khraban, the Chief Executive Officer at Proxima Research International, directs the overarching corporate strategy and long-term vision for the organization. By aligning pharmaceutical market intelligence with client needs, the Chief Executive Officer ensures the company maintains a competitive edge in the global healthcare sector. Oleksandr Khraban oversees high-level partnerships and drives expansion initiatives across international markets to solidify the firm's position as a leader in data analytics. This leadership role involves constant collaboration with the board to refine business models and improve service delivery. Through rigorous oversight of corporate governance, the Chief Executive Officer fosters a culture of innovation and excellence. By prioritizing sustainable growth and operational efficiency, the Chief Executive Officer secures the company's financial health while delivering significant value to stakeholders within the complex pharmaceutical landscape.
Oleksii Bedun - Group Chief Financial Officer
Oleksii Bedun, the Group Chief Financial Officer at Proxima Research International, manages the financial health, budgeting, and fiscal planning for the entire organization. Overseeing capital allocation and financial reporting, the Group Chief Financial Officer ensures transparency and compliance with international accounting standards. Oleksii Bedun drives cost-optimization strategies that improve margins while supporting investment in new research capabilities. This leadership role involves providing critical financial analysis to the executive team to guide strategic decision-making and resource distribution. By monitoring cash flow and managing financial risks, the Group Chief Financial Officer secures the company's ability to fund future growth initiatives. Through rigorous oversight of fiscal operations, the Group Chief Financial Officer maintains the financial stability necessary to navigate the competitive pharmaceutical market, ensuring that all business activities align with the long-term economic objectives of the firm.
Nataliya Tadeyeva - Chief Operating Officer (Up To 600 Employees In 5 Countries)
Nataliya Tadeyeva, the Chief Operating Officer (Up To 600 Employees In 5 Countries) at Proxima Research International, directs the daily operational workflows and cross-border service delivery across the company's international footprint. Overseeing the coordination between regional teams, the Chief Operating Officer (Up To 600 Employees In 5 Countries) ensures that research projects meet strict quality standards and delivery timelines. Nataliya Tadeyeva optimizes internal processes to enhance productivity and streamline communication across the five countries of operation. This role involves managing the logistical complexities of a multi-national workforce to ensure seamless service execution. By implementing standardized operational procedures, the Chief Operating Officer (Up To 600 Employees In 5 Countries) drives efficiency and consistency in all client engagements. Through proactive management of operational resources, the Chief Operating Officer (Up To 600 Employees In 5 Countries) supports the company's ability to scale effectively while maintaining high service levels.
Evgeniy Kunda - Chief Revenue Officer
Evgeniy Kunda, the Chief Revenue Officer at Proxima Research International, manages all commercial activities and sales strategies designed to maximize market penetration. Overseeing the alignment of product offerings with client requirements, the Chief Revenue Officer drives revenue growth through targeted business development initiatives. Evgeniy Kunda monitors sales performance metrics and optimizes pricing models to ensure consistent profitability across diverse pharmaceutical segments. This role requires close coordination with marketing and product teams to capture emerging opportunities in the healthcare data space. By implementing robust sales processes, the Chief Revenue Officer enhances customer acquisition and retention rates. Through strategic planning and execution, the Chief Revenue Officer strengthens the company's market presence, ensuring that revenue streams remain resilient against industry fluctuations while supporting the broader mission of providing actionable intelligence to pharmaceutical partners.
Artem Andruschenko - Chief Information Officer
Artem Andruschenko, the Chief Information Officer at Proxima Research International, architects the technological infrastructure required to process and analyze vast amounts of pharmaceutical data. Overseeing the development of proprietary software platforms, the Chief Information Officer ensures the security and integrity of all digital assets. Artem Andruschenko drives the integration of advanced analytics and machine learning tools to enhance the quality of insights provided to clients. This leadership role involves managing complex IT projects and coordinating with cross-functional teams to support digital transformation efforts. By maintaining a scalable and reliable technical environment, the Chief Information Officer enables the company to deliver high-performance solutions to the global pharmaceutical industry. Through continuous innovation in data processing, the Chief Information Officer secures the firm's technological advantage, ensuring that all information systems support the strategic objectives of the organization.
Anatolii Shapovalov - Chief Human Resources Officer
Anatolii Shapovalov, the Chief Human Resources Officer at Proxima Research International, directs talent acquisition, employee development, and organizational culture initiatives. Overseeing the recruitment of specialized professionals, the Chief Human Resources Officer ensures the company maintains a workforce capable of delivering high-level pharmaceutical research and analytics. Anatolii Shapovalov designs performance management systems that align individual contributions with corporate goals. This role involves fostering an inclusive environment that promotes professional growth and retention across all departments. By implementing effective human capital strategies, the Chief Human Resources Officer supports the company's operational scale and long-term stability. Through the development of comprehensive training programs, the Chief Human Resources Officer ensures that the team remains at the forefront of industry knowledge. Ultimately, the Chief Human Resources Officer builds a resilient organizational structure that empowers employees to achieve excellence in every project.
Explore Leadership Teams in Manufacturing
BeOne Medicines is a global biotechnology company focused on developing next-generation cancer treatments through innovative research and cutting-edge therapies. The company is committed to making these treatments accessible to patients worldwide, emphasizing speed, equity, and affordability in delivering care. Guided by the principle that cancer knows no borders, BeOne Medicines operates with a global perspective, striving to expand the reach of life-saving therapies and improve outcomes for patients everywhere.
Company Leadership
MD
YY
DA
Boehringer Ingelheim is a privately held, research-driven pharmaceutical company headquartered in Ingelheim am Rhein, Germany, founded in 1885. The company researches, develops, and manufactures prescription medicines and healthcare products across three core business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing. Its primary therapeutic focus areas include respiratory diseases, oncology, immunology, cardiometabolic conditions, and central nervous system disorders. Boehringer Ingelheim also develops and manufactures veterinary products for companion animals, livestock, and poultry. Operating in over 100 countries with more than 53,000 employees globally, the company maintains a broad network of research, manufacturing, and commercial sites across Europe, North America, and Asia. It is one of the largest privately owned pharmaceutical companies in the world.
Company Leadership JB

JM
SY
Fresenius Kabi, a subsidiary of Fresenius, is a global health care company that specializes in medicines and technologies for infusion, transfusion, and clinical nutrition. Fresenius Kabi is headquartered in Bad Homburg, Germany with locations around the world.
Company Leadership SM
RT

Founded in 1987, Integrated DNA Technologies, Inc. headquartered in Coralville, Iowa, is the supplier of custom nucleic acids, serving the areas of academic research, biotechnology, clinical diagnostics, and pharmaceutical development. The company develops, manufactures, and markets nucleic acid products for the life sciences industry.
Company Leadership AA
MM
AM
CL